ISPOR’s Rob Abbott on why RWE moved to number two in the 2026-2027 HEOR Trends Report, and what wearables, data fragmentation, and HARPER+ mean for clinical platforms.
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
- Is It Time To Replace RECIST — Or Just Add AI?
- Clinical Research Has System Sprawl Problem
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
- Why Patients Drop Out And How To Stop Them
- Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials
- AI In Clinical Trials: Real Impact, Real Limits, What's Next
- RWD Helps Researchers Include More Patients In Lymphoma Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Responsible Use Of AI In Healthcare: Work In Progress
Delve into the transformative role and potential benefits of artificial intelligence (AI) in healthcare and learn why it's crucial to carefully consider and plan for the responsible use of AI.
-
Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development
Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.
-
The Significance Of Quality Data In Meeting FDA Regulatory Scrutiny
Data Science expert Rod McGlashing explains how scrutiny from the FDA spurs regulatory compliance, resulting in better data quality and the creation of optimal applications for intellectual property.
-
Key To A Faster, More Flexible Clinical Trial Process
Discover how a single, integrated data analytics and visualization platform, supported by an experienced partner, can help you move your investigational product to market more quickly.
-
How To Improve Patient Outcomes Using eSource Software In Clinical Trials
As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.
-
Bespoke RTSM Systems Empower Precision Medicine
Randomization & trial supply management (RTSM) are critical functions of clinical trial IRT systems, supporting patient randomization plus managing drug inventory, site resupply, and participant dispensation.
-
5 Key Takeaways From The FDA's Real-World Evidence Guidance
With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.
-
Three Benefits Of Centralizing Global Content For eCOA Migration
Now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.
-
What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution
Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?
-
How To Improve Patient Engagement In Clinical Trials
Stronger patient engagement improves recruitment, retention, and data quality. Reducing burden, improving communication, and meeting real needs can transform trials and keep studies on track.
RECENT NEWSLETTERS
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up
- 03.26.26 -- AI, Telehealth & The Tools Reshaping Clinical Trials